1 year return (CAGR)
-11.19%
Arcturus Therapeutics Holdings Inc Exchange (NASDAQ, USD)
ARCT
14.12
-0.90 (-5.32%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-18.11%
5 year return (CAGR)
-21.35%
10 year return (CAGR)
-7.23%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
455.62M
Price/Sales
19.14
Ent value
316.64M
Price/Book
2.65
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-7.53%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.85 |
| Daily high | 17.75 |
| Daily low | 15.93 |
| Daily Volume | 840K |
| All-time high | 178.57 |
| 1y analyst estimate | 22.30 |
| Beta | 2.48 |
| EPS (TTM) | -3.28 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ARCT | S&P500 | |
| Current price drop from All-time high | -92.09% | -1.38% |
| Highest price drop | -97.70% | -56.47% |
| Date of highest drop | 28 Dec 2018 | 9 Mar 2009 |
| Avg drop from high | -79.93% | -10.68% |
| Avg time to new high | 160 days | 12 days |
| Max time to new high | 3257 days | 1805 days |
News
